Antidepressant treatment with venlafaxine and mirtazapine

• Verfasst von: Deuschle, Michael [VerfasserIn]
• Titel: Antidepressant treatment with venlafaxine and mirtazapine
• Titelzusatz: no effect on serum concentration of Vascular Endothelial Growth Factor (VEGF)
• Verf.angabe: M. Deuschle, M. Gilles, B. Scharnholz, K.G. Kahl
• Jahr: 2015
• Umfang: 2 S.
• Fussnoten: Gesehen am 19.12.2017
• Titel Quelle: Enthalten in: Pharmacopsychiatry
• Ort Quelle: Stuttgart [u.a.] : Thieme, 1984
• Jahr Quelle: 2015
• Band/Heft Quelle: 48(2015), 07, Seite 292-293
• ISSN Quelle: 1439-0795
• DOI: doi:10.1055/s-0035-1555849
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1566536308

Abstract

Introduction: Depression, stress and antidepressant treatment have been found to modulate the expression of growth factors. Methods: We studied depressed patients receiving randomized treatment with venlafaxine or mirtazapine for 28 days. Results: There was no significant difference between baseline VEGF concentrations in depressed patients compared to healthy controls. We found no significant effect of antidepressant treatment on serum VEGF. Discussion: In contrast to serum BDNF, VEGF may not be a suitable biomarker for effects of antidepressant treatment with venlafaxine or mirtazapine.